ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$1.29 USD
+0.03 (2.38%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.35 +0.06 (4.65%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Earnings News For IPA
-
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Tops Revenue Estimates
-
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*
-
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
-
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024*
-
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Tops Revenue Estimates
-
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024
-
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 on September 14, 2023
-
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.
-
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimates
-
IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023
-
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023
-
IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023
-
IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022